CN1056289C - Antiphthitic medicine - Google Patents
Antiphthitic medicine Download PDFInfo
- Publication number
- CN1056289C CN1056289C CN96102473A CN96102473A CN1056289C CN 1056289 C CN1056289 C CN 1056289C CN 96102473 A CN96102473 A CN 96102473A CN 96102473 A CN96102473 A CN 96102473A CN 1056289 C CN1056289 C CN 1056289C
- Authority
- CN
- China
- Prior art keywords
- weight portion
- herba
- weight portions
- medicine
- lupuli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses novel antiphthisic medicine for treating tuberculosis. The present invention comprises lupulus, humulene, Lysionotus pauciflorus, houttuynia, scutellaria, stemona and bletilla striata. The present invention has excellent therapeutic effect on various kinds of tuberculosis.
Description
The present invention is a kind of antituberculosis drug, and it is that active ingredient is made with the Chinese herbal medicine, has treatment all kinds Chinese patent medicine lungy.
Tuberculosis is a kind of chronic infectious disease, because of infecting tubercule bacillus, falls ill in the low situation of resistance of human body.It is a kind of systemic disease, each organ all can be invaded and, and with pulmonary tuberculosis for the most common, its pathological characters is that tubercle, infiltration, caseation and cavity form.Pulmonary tuberculosis can roughly reduce four kinds of main types: 1. primary pulmonary tuberculosis; 2. the phthisis miliaris that causes of hematogenous spread; 3. infiltrative pulmonary tuberculosis; 4. chronic fibro cavernous pulmonary tuberculosis.For phthisical diagnosis, mainly find the most of state of an illness complexity of this disease at present, must analyze, just can make correct diagnosis in conjunction with many-sided data by physical examination with in outpatient service.The general means such as tuberculin test, X ray examination, biopsy that adopt are made a definite diagnosis.For phthisical treatment, general at present antituberculotics, for example isoniazid of adopting, medicines such as isoniazid, this class antituberculotics no doubt has antibacterial action, but it still works by immune function in the body, impels focus to dissipate and healing, after Drug therapy finishes, keep healing of focus, exempt to cause recurrence, the resistance of human body plays more important role undoubtedly, and these anti-consumptive disease Western medicine all have infringement to liver mostly, and taking in human body for a long time has adverse influence.We have developed a kind of effective and nontoxic Antiphthitic medicine through secular scientific research and clinical observation.
Therefore, the present invention seeks to produce a kind of antituberculotics that effectively has no side effect.
The prescription of medicine of the present invention is composed as follows:
Flos lupuli (Flos Humuli Lupuli): 55-65 weight portion
Herba humuli scandentis: 55-65 weight portion
Herba Lysionoti Pauciflori: 45-55 weight portion
Herba Houttuyniae: 45-55 weight portion
Radix Scutellariae: 25-35 weight portion
The Radix Stemonae: 20-30 weight portion
The Pseudobulbus Bletillae (Rhizoma Bletillae): 20-30 weight portion
The optimum weight proportioning of above-mentioned each medicine components is:
Flos lupuli (Flos Humuli Lupuli): 60
Herba humuli scandentis: 60
Herba Lysionoti Pauciflori: 50
Herba Houttuyniae: 50
Radix Scutellariae: 30
The Radix Stemonae: 25
The Pseudobulbus Bletillae (Rhizoma Bletillae): 25
The preferred Radix Scutellariae (processed) of said Radix Scutellariae in the above-mentioned prescription, the process of preparing Chinese medicine of the Chinese herbal medicine of respectively distinguishing the flavor of described in the prescription are all concocted by the conventional method of pharmacopeia regulation.
Aforementioned pharmaceutical compositions can be made medicament commonly used clinically according to the formulation method of routine as the drug effect component, comprises that tablet, pill, powder, powder, unguentum, oral liquid, capsule etc. can add excipient commonly used in preparation process
The powder preparation method of medicine of the present invention is:
Take by weighing medicine by prescription, dry, be ground into fine powder, cross 80 mesh sieves, mix all to go into, packing promptly.
The above-mentioned medicated powder that makes with the close mixing of refining, can be made honeyed pill
Perhaps, cross 120 mesh sieves with the above-mentioned medicated powder that makes, encapsulated, make capsule
The various types of pulmonary tuberculosis of Drug therapy of the present invention are through clinical 150 routine patient's checkings, its effective percentage 100%.This medicine has antibacterial action, to all kinds of pulmonary tuberculosis with antitubercular agent poor effect such as isoniazid, streptomycins or have chemical sproof, after taking this product remarkable result is arranged all, the symptom of pulmonary tuberculosis is alleviated gradually to whole disappearances, inflammation is eliminated gradually, it is closed that the cavity is contracted to the cavity, and the expectorant bacterium is turned out cloudy, physical recovery health.This medicine also all has in various degree inhibitory action to other various pathogenic bacterium.In addition, medicine of the present invention also has tangible antivirus action, has that enhancing human body immunity function, hemostasis, heat-clearing and toxic substances removing, hard masses softening and resolving, expelling wind and activating blood circulation, preventing phlegm from forming and stopping coughing, lung heat clearing lung moistening expectorant, relieving cough and expelling phlegm are relievingd asthma, a function of remuval of damp and hot subduing inflammation, analgesic cooling, astringing to arrest bleeding, detumescence and promoting granulation.
Embodiment 1
Prescription:
Flos lupuli (Flos Humuli Lupuli): 600 gram rule grass: 600 grams
Herba Lysionoti Pauciflori: 500 gram Herba Houttuyniae: 500 grams
Radix Scutellariae (processed): the 300 gram Radixs Stemonae: 250 grams
The Pseudobulbus Bletillae (Rhizoma Bletillae): 250 grams
Above seven flavor medicine thing, after concocting according to a conventional method, oven dry is ground into fine powder, crosses 80 mesh sieves, packing, every bag 2 gram.
Embodiment 2
Flos lupuli (Flos Humuli Lupuli): 600 gram Herba humuli scandentis: 600 grams
Herba Lysionoti Pauciflori: 500 gram Herba Houttuyniae: 500 grams
Radix Scutellariae (processed): the 300 gram Radixs Stemonae: 250 grams
The Pseudobulbus Bletillae (Rhizoma Bletillae): 250 grams
Above seven flavor medicine thing is concocted according to a conventional method, after the oven dry, is ground into fine powder, crosses 120 mesh sieves, and medicated powder is encapsulated, and every capsules contains 1 gram medicine.
Embodiment 3
Prescription:
Flos lupuli (Flos Humuli Lupuli): 6 kilograms of Herba humuli scandentis: 6 kilograms
Herba Lysionoti Pauciflori: 5 kilograms of Herba Houttuyniae: 5 kilograms
Radix Scutellariae: 3 kilograms of Radixs Stemonae: 2.5 kilograms
The Pseudobulbus Bletillae (Rhizoma Bletillae): 2.5 kilograms
Above seven flavor medicine thing, after concocting according to a conventional method, oven dry is ground into fine powder, crosses 80 mesh sieves, and making pellets by mixing medical powder with honey, every ball weigh 10 grams
The instructions of taking of medicine of the present invention is:
If take medicated powder, every day 3 times is for oral administration, and 2 grams for oral administration at every turn take with eliminating cold for resuscitation water or rice water, before drink half an hour for oral administration, other dosage form is taken by the corresponding dosage conversion.
Claims (6)
1. treat the tuberculosis compositions for one kind, it is characterized in that: it is made by following component:
Flos lupuli (Flos Humuli Lupuli): 55-65 weight portion
Herba humuli scandentis: 55-65 weight portion
Herba Lysionoti Pauciflori: 45-55 weight portion
Herba Houttuyniae: 45-55 weight portion
Radix Scutellariae: 25-35 weight portion
The Radix Stemonae: 20-30 weight portion
The Pseudobulbus Bletillae (Rhizoma Bletillae): 20-30 weight portion.
2. according to the pharmaceutical composition of claim 1, it is characterized in that it is made by following component:
Flos lupuli (Flos Humuli Lupuli): 60 weight portions
Herba humuli scandentis: 60 weight portions
Herba Lysionoti Pauciflori: 50 weight portions
Herba Houttuyniae: 50 weight portions
Radix Scutellariae: 30 weight portions
The Radix Stemonae: 25 weight portions
The Pseudobulbus Bletillae (Rhizoma Bletillae): 25 weight portions.
3. according to the pharmaceutical composition of claim 1 or 2, wherein said Radix Scutellariae is a Radix Scutellariae (processed).
4. according to claim 1 or 2 said pharmaceutical compositions, it is a pharmaceutical dosage form commonly used clinically.
5. according to the said pharmaceutical composition of claim 4, wherein said pharmaceutical dosage form comprises tablet, powder, pill, unguentum, powder, oral liquid, capsule.
6. according to claim 4 pharmaceutical composition, wherein can also add excipient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96102473A CN1056289C (en) | 1996-03-15 | 1996-03-15 | Antiphthitic medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96102473A CN1056289C (en) | 1996-03-15 | 1996-03-15 | Antiphthitic medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1139001A CN1139001A (en) | 1997-01-01 |
| CN1056289C true CN1056289C (en) | 2000-09-13 |
Family
ID=5117590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96102473A Expired - Fee Related CN1056289C (en) | 1996-03-15 | 1996-03-15 | Antiphthitic medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1056289C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169165A (en) * | 2015-11-02 | 2015-12-23 | 任纪通 | Traditional Chinese medicine composite for treating tuberculosis |
| CN105327229A (en) * | 2015-11-25 | 2016-02-17 | 赵连祺 | Traditional Chinese medicine composition for treating silicosis and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1076483A (en) * | 1992-03-17 | 1993-09-22 | 西安汉斯啤酒饮料总厂 | The production method of gynostemma pentaphylla beer |
| CN1096455A (en) * | 1993-12-14 | 1994-12-21 | 刘兴旺 | The Chinese patent medicine of a kind of prevention and treatment neurasthenia and " preexam psychentonia syndrome " |
-
1996
- 1996-03-15 CN CN96102473A patent/CN1056289C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1076483A (en) * | 1992-03-17 | 1993-09-22 | 西安汉斯啤酒饮料总厂 | The production method of gynostemma pentaphylla beer |
| CN1096455A (en) * | 1993-12-14 | 1994-12-21 | 刘兴旺 | The Chinese patent medicine of a kind of prevention and treatment neurasthenia and " preexam psychentonia syndrome " |
Non-Patent Citations (3)
| Title |
|---|
| 黑龙江中医药1991(5) 1991.5.31 马晓平等，结核散治疗空洞型结核107例疗效观察 * |
| 黑龙江中医药1991(5) 1991.5.31 马晓平等，结核散治疗空洞型结核107例疗效观察;黑龙江中医药1992(4) 1992.4.30 结核散并用化学疗法治疗肺结核六十例临床观察 * |
| 黑龙江中医药1992(4) 1992.4.30 结核散并用化学疗法治疗肺结核六十例临床观察 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1139001A (en) | 1997-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1483463A (en) | Anti-virus Chinese medicine composition and preparation process thereof | |
| CN1899535A (en) | Method for preparing dermopathic blood toxic capsule | |
| CN1210047C (en) | Medicine for treating cold and preparation method thereof | |
| CN111249390A (en) | Forsythia-astragalus root compound preparation and preparation method and application thereof | |
| CN1302800C (en) | Chinese traditional medicine preparation for curing gastric ulcer | |
| CN1272066C (en) | Medicinal composition for relieving itching | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1056289C (en) | Antiphthitic medicine | |
| CN1166388C (en) | Medicine for treating nosal inflammation | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
| CN106974958B (en) | Recipe of 'RongjinNiantong' and its prepn and use | |
| CN1404868A (en) | Chinese medicinal preparation for treating pyretic stranguria | |
| CN101732469B (en) | Application of Chinese medicinal composition in preparation of medicament for treating aphonia | |
| CN1943746A (en) | A Chinese traditional medicinal preparation for treatment of urticaria | |
| CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
| CN1059098C (en) | Medicine for curing tooth-ache and its preparation | |
| CN1188000A (en) | Intestinal microecological preparation | |
| CN1813925A (en) | Chinese medicine formulation for treating pharynx and larynx disease and its preparing method | |
| CN1827160A (en) | Chinese medicinal composition for treating enteritis | |
| CN1088592C (en) | Medicine for treating peptic ulcer | |
| CN102908529B (en) | Traditional Chinese medicine for treating lung cancer | |
| CN1440777A (en) | Acne treating medicine | |
| CN1220508C (en) | Medicine for curing diseases of digestive system and its preparation method | |
| CN1824176A (en) | Chinese medicinal preparation for anti inflammation and heat resolution and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1010578 Country of ref document: HK |